Benitec Biopharma DPO Ratio 2011-2026 | BNTC

Annual DPO Ratio Benitec Biopharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-556	1.26 K	469	233	1.41 K	6.94 K	6.94 K	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
6.94 K	-556	2.38 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Cerus Corporation CERS	242	$ 2.72	33.99 %	$ 518 M	USA
ACADIA Pharmaceuticals ACAD	75.2	$ 21.95	-2.23 %	$ 3.64 B	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Berkeley Lights BLI	135	-	-7.31 %	$ 87 M	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Cardiff Oncology CRDF	406	$ 1.71	-1.16 %	$ 114 M	USA
Caladrius Biosciences CLBS	51.2	-	-16.75 %	$ 25.8 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
Deciphera Pharmaceuticals DCPH	2.2 K	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Dynavax Technologies Corporation DVAX	52.8	-	-	$ 2.02 B	USA
Eiger BioPharmaceuticals EIGR	84.3 K	-	-9.21 %	$ 2.55 M	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Evogene Ltd. EVGN	62.6	$ 0.81	3.33 %	$ 27.9 M	Israel